Well.. Q1 result was really good and usually Q2 is better in terms of clinical trials sales contracts but the last quarter was not that good almost on par with previous years Q2 result. If there's an indication that the current quarter is seeing exponential growth like Q1, we'll probably do ok but it's anyone's guess.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.000(0.00%) |
Mkt cap ! $278.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5651 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 2298 | 1 |
View Market Depth
| Last trade - 08.20am 04/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |
Day chart unavailable